Showing results (131-140 of 226) with videos related to
Sort By:
Pageof 23
Pharmacology & Therapeutics|August 22, 2012
Prevailing importance of the hedgehog signaling pathway and the potential for treatment advancement in sarcomaFergal C Kelleher, Jason E Cain, Joan M Healy, et al.Oncoimmunology|December 18, 2012
Studying the role of the immune system on the antitumor activity of a Hedgehog inhibitor against murine osteosarcomaChristophe Paget, Helene Duret, Shin Foong Ngiow, et al.Clinical Sarcoma Research|December 11, 2013
Intra-patient dose escalation in Ewing's sarcoma treated with vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide and etoposide: a retrospective reviewJeremy Lewin, Samantha Wieringa, Marnie Collins, et al.The Journal of Pharmacology and Experimental Therapeutics|May 28, 2004
Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activationDavid M Thomas, Paul D Walker, Joyce A Benjamins, et al.JAMA Oncology|August 4, 2017
Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging: A Meta-analysisMandy L Ballinger, Ana Best, Phuong L Mai, et al.Neuroscience Letters|September 1, 2004
Microglial activation is a pharmacologically specific marker for the neurotoxic amphetaminesDavid M Thomas, Jennifer Dowgiert, Timothy J Geddes, et al.Journal of Neurochemistry|August 21, 2010
The role of endogenous serotonin in methamphetamine-induced neurotoxicity to dopamine nerve endings of the striatumDavid M Thomas, Mariana Angoa Pérez, Dina M Francescutti-Verbeem, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 7, 2006
HES1 cooperates with pRb to activate RUNX2-dependent transcriptionJong-Seo Lee, David M Thomas, Gabriel Gutierrez, et al.Brain Research|April 4, 2006
Differential tissue distribution of tryptophan hydroxylase isoforms 1 and 2 as revealed with monospecific antibodiesStacey A Sakowski, Timothy J Geddes, David M Thomas, et al.Cancer Cell|June 11, 2024
Testing dilemmas in the clinic: Lessons learned from biomarker-based drug developmentSahar Barjesteh van Waalwijk van Doorn-Khosrovani, Olga Kholmanskikh Van Criekingen, Simone Koole, et al.Pageof 23